“Monitoring Kidney Function Through the Use of Candesartan, Telmisartan or Valsartan Antihypertensive Therapy towards Patients CKD”, MKMI, vol. 18, no. 1, pp. 1–9, Mar. 2022, doi: 10.30597/mkmi.v18i1.17780.